Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

Background Local and/or regional recurrence and metachronous primary tumor arising in a
previously irradiated area are rather frequent events in patients with head and neck …

Patients with advanced head and neck cancers who are not eligible for curative treatment
represent a challenging cohort of patients to manage given the complexity and severity of …

Retreatment of recurrent or second primary head and neck cancers occurring in a previously
irradiated field is complex. Few guidelines exist to support practice. We performed an …

Background and purpose Head and neck squamous cell carcinoma (HNSCC) that recurs
locally is a therapeutic challenge. We investigated the efficacy of boron neutron capture …

Purpose: To assess the effect of stereotactic body radiotherapy (SBRT) dose and tumor
volume on outcomes in patients with recurrent, previously irradiated squamous cell …

Purpose: Locally recurrent head and neck squamous cell carcinoma can be treated with
curative intent by surgical salvage or reirradiation with or without chemotherapy. We have …

We evaluated the efficacy and safety of stereotactic body radiation therapy (SBRT) for
patients with head and neck tumors. From April 2005 through April 2008, 34 patients with …

Advances in radiotherapy planning and delivery have been used to treat patients with
limited metastatic disease. With these techniques, high rates of treated metastasis control …

Simple Summary Currently, Stereotactic Body Radiation Therapy (SBRT) is reserved for
head and neck cancer (HNC) patients who are not suitable candidates for conventional …